Fact CheckerSign in

NCT07253363Active, not recruiting

Circulating Activin-A and FSTL3 in Precapillary Pulmonary Hypertension

Investigation of Circulating ACTIvin-A and FSTL3 as Prognostic and Predictive BIOmarkers in Precapillary Pulmonary Hypertension

Source: ClinicalTrials.gov · Last updated 28 Nov 2025

Brief summary (registry, in English)

The ACTIOBIO study aims to evaluate the prognostic value of Activin-A and FSTL3 in a large cohort of patients with precapillary pulmonary hypertension, including pulmonary arterial hypertension (Group 1), pulmonary hypertension associated with lung diseases (Group 3), and chronic thromboembolic pulmonary hypertension (Group 4).

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
550 (estimated)
First submitted
19 Nov 2025
Start date
1 Mar 2024
Primary completion date
Apr 2026
Lead sponsor
Assistance Publique - Hôpitaux de Paris
NCT number
NCT07253363

What you commit to

  • Study type: Interventional
  • Planned participants: 550
  • From 1 Mar 2024 to the primary completion date, Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Male or female ≥ 18 years of age
  • Precapillary PH documented by right heart catheterization:
    • mean pulmonary arterial pressure (mPAP) \> 20 mmHg,
    • pulmonary artery wedge pressure (PAWP) ≤ 15 mmHg;
    • pulmonary vascular resistance (PVR) \> 2 WU
  • Pulmonary arterial hypertension (group 1) or PH associated with lung disease (group 3) or chronic thromboembolic PH (group 4)
  • Patient registered in the French PH registry
  • Patient capable of understanding the study procedures
  • Affiliation to a social security regime (or exemption)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hôpital Bicêtre (AP-HP.Université Paris-Saclay), Service de Pneumologie et Soins Intensifs
Coordinator of this site? Confirm its status
Le Kremlin-BicêtreFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.